Marathon Trading Investment Management LLC Purchases New Shares in The Clorox Company $CLX

Marathon Trading Investment Management LLC purchased a new stake in The Clorox Company (NYSE:CLX) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 10,663 shares of the company’s stock, valued at approximately $1,075,000.

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox in the 3rd quarter valued at $25,000. Darwin Wealth Management LLC acquired a new position in shares of Clorox in the 2nd quarter valued at $29,000. Vision Financial Markets LLC boosted its position in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the period. Ameriflex Group Inc. boosted its position in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the period. Finally, Elevated Capital Advisors LLC acquired a new position in shares of Clorox in the 4th quarter valued at $43,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Trading Down 0.1%

Shares of NYSE CLX opened at $96.74 on Monday. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The firm has a market capitalization of $11.70 billion, a PE ratio of 15.70, a PEG ratio of 0.50 and a beta of 0.56. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The business has a 50-day moving average price of $96.43 and a two-hundred day moving average price of $105.20.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the company posted $1.45 EPS. The business’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts predict that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Jefferies Financial Group decreased their price target on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. TD Cowen increased their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research report on Tuesday, March 31st. Morgan Stanley decreased their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, Wells Fargo & Company decreased their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.